Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03233607 · ClinicalTrials.gov registry record
Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 100
- Enrollment target
NCT03233607: Completed study, sponsored by Columbia University.
NCT03233607 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03233607 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood loss (EBL) and quantitative blood loss (QBL).
Primary Outcome
Maternal hemoglobin will be measured on postpartum day 1 to day 2
Interventions
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2019-04-23 |
What the finished NCT03233607 record still lists
NCT03233607 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT03233607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03233607 about?
NCT03233607 is a clinical study titled "Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery". This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood ...
What is the current status of trial NCT03233607?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-03-20. Estimated completion is 2019-04-23.
What interventions are being tested in trial NCT03233607?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT03233607?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI